Related Experiment Video
Updated: May 3, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
9.2K
Endobronchial/tracheal metastasis and sudden death
1School of Medical Sciences, The University of Adelaide, Frome Rd., Adelaide, SA, Australia.
Journal of Forensic Sciences
|February 8, 2014
Summary
Sudden airway obstruction by a rare endobronchial metastasis from renal cell carcinoma caused a patient's death. This case highlights an unusual complication of disseminated cancer, emphasizing the importance of considering rare metastatic sites.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Endobronchial and endotracheal metastases are uncommon causes of airway obstruction.
- Renal cell carcinoma (RCC) is known for its metastatic potential, but airway involvement is exceptionally rare.
Observation:
- A 62-year-old male with a history of renal cell carcinoma presented with hemoptysis, sudden dyspnea, and cyanosis.
- Autopsy revealed disseminated RCC with metastases to the lungs, lymph nodes, and brain.
- A solitary papillomatous metastasis was found obstructing the carina, trachea, and main bronchi.
Findings:
- The patient's death was attributed to acute airway obstruction caused by a metastatic deposit at the tracheal bifurcation.
- This represents an extremely rare instance of sudden death due to endobronchial metastasis from renal cell carcinoma.
Implications:
- This case underscores the critical need to consider rare metastatic presentations in patients with advanced malignancies.
- Clinicians should be aware of the potential for endobronchial metastases to cause acute, life-threatening airway compromise.
- Pathological examination is crucial for identifying unusual metastatic sites and determining the cause of death in complex cases.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:27Pneumothorax-II
1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.7K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:17Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
01:08Pneumothorax II: Pathophysiology
55
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
55
01:17Pulmonary Cycle: Exhalation
5.2K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K